Acrylamide ≥99 %, BioScience Grade, 4x crystal- line

Hazard statements (CLP)

H301, H312, H312+H332, H315, H317, H319, H332, H340, H350, H361f, H372

Code

Statements

H301

Toxic if swallowed

SECTION 2: Hazards identification

According to Regulation (EC) No 1272/2008 [CLP Classification of the substance or mixture

Hazard categories

Cat- Hazard class and Hazard egory category statement 3.1O Acute toxicity (oral) Acute Tox. 3 H301 3.1D Acute toxicity (dermal) Acute Tox. 4 H312 3.1I Acute toxicity (inhal.) Acute Tox. 4 H332 3.2 Skin corrosion/irritation Skin Irrit. 2 H315 3.3 Serious eye damage/eye irritation Eye Irrit. 2 H319 3.4S Skin sensitisation Skin Sens. 1 H317 3.5 Germ cell mutagenicity 1B Muta. 1B H340 3.6 Carcinogenicity 1B Carc. 1B H350 3.7 Reproductive toxicity Repr. 2 H361f 3.9 Specific target organ toxicity - repeated exposure STOT RE 1 H372 For full text of abbreviations: see SECTION 16

Most important adverse effects

Delayed or immediate effects can be expected after short or long-term exposure

Signal word

Danger Danger Not required

Hazard pictograms

GHS06, GHS08 H301 Toxic if swallowed. H317 May cause an allergic skin reaction. H340 May cause genetic defects. H350 May cause cancer. H361f Suspected of damaging fertility. H372 Causes damage to organs through prolonged or repeated exposure. P201 Obtain special instructions before use. P280 Wear protective gloves/protective clothing/eye protection/face protection. P302+P352 IF ON SKIN: Wash with plenty of soap and water. P308+P313 IF exposed or concerned: Get medical advice/attention. Labelling of packages where the contents do not exceed 10 ml

Hazard statements

H301 Toxic if swallowed H312+H332 Harmful in contact with skin or if inhaled H315 Causes skin irritation H317 May cause an allergic skin reaction H319 Causes serious eye irritation H340 May cause genetic defects H350 May cause cancer H361f Suspected of damaging fertility H372 Causes damage to organs through prolonged or repeated exposure Not required

Prevention

P201 Obtain special instructions before use P280 Wear protective gloves/protective clothing/eye protection/face protection

Response

P302+P352 IF ON SKIN: Wash with plenty of soap and water P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P308+P313 IF exposed or concerned: Get medical advice/attention For professional users only Labelling of packages where the contents do not exceed 125 ml

Precautionary statements

Not required

Results of PBT and vPvB assessment

According to the results of its assessment, this substance is not a PBT or a vPvB. Endocrine disrupting properties Does not contain an endocrine disruptor (ED) at a concentration of ≥ 0,1%.

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No 1272/2008 (CLP) Section Hazard class Cat- Hazard class and Hazard egory category statement 3.1O Acute toxicity (oral) 3 Acute Tox. 3 H301 3.1D Acute toxicity (dermal) 4 Acute Tox. 4 H312 3.1I Acute toxicity (inhal.) 4 Acute Tox. 4 H332 3.2 Skin corrosion/irritation 2 Skin Irrit. 2 H315 3.3 Serious eye damage/eye irritation 2 Eye Irrit. 2 H319 3.4S Skin sensitisation 1 Skin Sens. 1 H317 3.5 Germ cell mutagenicity 1B Muta. 1B H340 3.6 Carcinogenicity 1B Carc. 1B H350 3.7 Reproductive toxicity 2 Repr. 2 H361f 3.9 Specific target organ toxicity - repeated exposure 1 STOT RE 1 H372 For full text of abbreviations: see SECTION 16 The most important adverse physicochemical, human health and environmental effects Delayed or immediate effects can be expected after short or long-term exposure.